Global Ganja Report

With the Democratic horserace having narrowed into a two-man contest, cannabis voters appear to face a clear-cut choice: Bernie Sanders supports legalization, while Joe Biden has only in recent years come to support decrim. A look at the details, however, reveals that Bernie too has compromised with the Drug War establishment in the past.

Growing numbers around the United States and the world are using cannabis to treat a wide spectrum of medical conditions, and legal space is widening for them to do so. So it's a particular irony that hospitals as a rule bar cannabis from their premises. More voices in the medical industry are now grappling with this dilemma.

There has been significant progress toward cannabis legalization in the United States and globally over the past years, but pockets persist of the most repressive and reactionary prohibition. What are the prospects for expanding cannabis freedom in the coming year?

In a Capitol Hill hearing that advocates hailed as “historic,” numerous Congress members openly embraced lifting the federal strictures on cannabis—and even outright legalization. The discussion was particularly framed in terms of recognizing and correcting the racial and social iniquities of cannabis prohibition and the "war on drugs."

The Cannabis Cultural Association won at least a limited legal victory, with a federal appeals court ruling that the DEA must consider with "alacrity" their petition to have cannabis rescheduled.

A new report by the British think-tank Prohibition Partners foresees a $5.8 billion cannabis market in Asia by 2024—if the tentative seeds of liberalization now witnessed across the continent in fact bear fruit.

There is a growing consensus among hemp advocates that the 0.3% limit for THC content is arbitrary and is holding back the industry. And the man widely credited with arriving at this limit himself agrees.

The Contested Border
"It seems like it is pretty much pulled out of air. We ought to be looking to science to determine an appropriate threshold, determine the level at which cannabis is psychoactive and make that the standard."

This typical view is offered by attorney Patrick Goggin of Hoban Law Group, the international firm specializing in cannabis. Goggin is one of the industry's legal heavy-hitters, and has particular experience in the question of the contested border between hemp and marijuana.

FDA commissioner Scott Gottlieb has suddenly announced that he is stepping down, leaving lots of unfinished business—including the status of CBD under the agency's regs. Biotech stocks are taking a tumble on the news, while tobacco is bullish and cannabis is mixed.